Results 131 to 140 of about 16,167 (200)

In Silico Investigation of Mineralocorticoid Receptor Antagonists: Insights into Binding Mechanisms and Structural Dynamics. [PDF]

Molecules
Liang JJ, Cao S, Hung A, El-Osta A, El-Osta A, Karagiannis TC, Young MJ.   +6 more
europepmc   +1 more source

Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses

, 2018
Mireille Fernet, Bruce Beckerman, Paula Abreu, Katharina Lins, John Vincent, Ellen Burgess   +5 more
openalex   +2 more sources

Mineralocorticoid Receptor Antagonists in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Zaheen M, Ferdous F, Amarasekera AT, Petutschnigg J, Edelmann F, Tan TC.   +5 more
europepmc   +1 more source

Recent advances in mineralocorticoid receptor antagonists for heart failure with preserved ejection fraction: focus on finerenone in the era of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists. [PDF]

Front Pharmacol
Wang TY, Zhang L, Wang HY, Jiang FF.
europepmc   +1 more source

Monitoring renal safety in mineralocorticoid receptor antagonist trials [PDF]

European Journal of Heart Failure, 2017
openaire   +2 more sources

Mineralocorticoid Receptor Antagonists and Cognitive Outcomes in Cardiovascular Disease and Beyond: A Systematic Review. [PDF]

J Pers Med
Pastena P, Campagnoli G, Rahmani AR, Kalogeropoulos AP.   +3 more
europepmc   +1 more source

Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials

, 2019
Susan Stienen, Patrick Rossignol, António S. Barros, Nicolas Girerd, Bertram Pitt, Faı̈ez Zannad, João Pedro Ferreira   +6 more
openalex   +2 more sources

Discontinuation and reinitiation of mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction. [PDF]

Eur J Heart Fail
Landucci L, Faxén UL, Benson L, Dahlström U, Carrero JJ, Savarese G, Lund LH.   +6 more
europepmc   +1 more source

Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death across cardio-kidney-metabolic diseases: A meta-analysis of randomized clinical trials. [PDF]

Eur J Heart Fail
Marques P, Zannad F, Ferreira JP.
europepmc   +1 more source

Aldosterone's impact on kidney health: exploring the benefits of mineralocorticoid receptor antagonists for renal protection. [PDF]

Am J Transl Res
Liu Z, Xie B, Pang S, Xie Y, Jili M, Mo Z, Li W, Yang R.   +7 more
europepmc   +1 more source